EMBO Meeting

Cellular Signaling & Molecular Medicine - Dubrovnik

May 29 - June 4, 2008, Croatia

 

Scientific program 2008

                                                                                                                                                
May 29 | May 30 | May 31 | June 1 | June 2 |June 3 | June 4

 

May 29  
16:00 Arrival and registration
 
20:00 Welcome Reception

 

May 30
 

Session I. From Bench to Bedside on Cancer Treatment
Chair: Giulio Superti-Furga, Austria

sponsored by

09:00-09:15 Opening remarks
Ivan Dikic, Manuela Baccarini, Joseph Schlessinger
09:15-10:00

Joseph Schlessinger, USA
Cell signaling by receptor tyrosine kinases: from basic principles to Cancer Therapy

10:00-10:30

Paul Manley, Switzerland
Nilotinib: From bench to bedside of a new therapy for chronic myelogenous leukaemia (CML)

10:30-11:00 Coffee break

11:00-11:30

Pier Paolo di Fiore, Italy
Numb controls the stem cell compartment in the normal breast gland and it is subverted in breast tumors
11:30-11:50

Andree Blaukat, Germany
c-Met as a target for cancer therapy – discovery of new highly selective tyrosine kinase inhibitors

11:50-12:10 Domagoj Vucic, USA
Targeting IAPs: TNFαlpha and ubiquitin connections
12:30-13:30 Lunch
 
 

Session II. Protein kinases and therapeutic interventions
Chair: Ruth Palmer, Sweden

14:00-14:30 Manuela Baccarini, Austria
Targets of the Raf pathway in tumorigenesis
14:30-15:00 Tony Hunter, USA
Signal Transduction in Cancer and the DNA Damage Response
15:00-15:30

Coffee break

15:30-16:00 Giulio-Superti Furga, Austria
Chemical and pathway proteomics for a postgenomic pharmacology
16:00-16:20

Felix Randow, UK
Somatic cell genetics for the study of signalling in innate immunity

16:20-16:40 Abigail Miller, USA
The early adenoviral protein E4-ORF1 activates PI3K through the PDZ containing proteins Dlg1, Mint1, Veli-3, and Cask
17:00-19:00 Poster session I.
18:00-18:30 Meet the Editor I.
  Free evening

 

May 31  
  Session III. Targeting signaling networks
Chair:
Johannes Bos, Holland
09:00-09:30 Tony Pawson, Canada
Adaptors, SH2 domains and tyrosine kinases: Back to the future
09:30-10:00

Ruth Palmer, Sweden
Anaplastic Lymphoma Kinase signaling, insights from the fruitfly

10:00-10:20

Noriko Gotoh, Japan
Signaling mechanisms in neural stem cells and cancer stem cells

10:20-11:00 Coffee break
11:00-11:30 Ivan Dikic, Germany
Targeting ubiquitin networks
11:30-12:00 Michael B. Yaffe, USA
Integration of Stress Kinase Pathways and DNA Damage Kinase Pathways in Tumor Cells Controls Survival after Genotoxic Stress
12:00-12:20 Katrin Rittinger, UK
Vav1 and activation of Rho-family GTPases - a new role for C1 domains?
12:30-15:00 Lunch and afternoon swimming break
   
 

Session IV. Dynamics of signaling pathways
Chair:
Manuela Baccarini, Austria

15:00-15:30

Marino Zerial, Germany
Genome-Wide Survey of Endocytosis by Quantitative Multi-Parametric Image Analysis

15:30-16:00 Johannes Bos, Holland
The regulation and function of Epac proteins
16:00-16:30

Coffee break

16:30-17:00

Alain Israel, France
Structure-function analysis of NEMO, the core element of the NF-kB cascade

17:00-17:20 Marta Miaczynska, Poland
Endocytic Cargo Transport via an APPL-positive Compartment
17:20-17:40

Domingo Barber, Spain
Involvement of phosphoinositide 3-kinase γ in T cell receptor-induced T cell activation

18:00-20:00 Poster session II.

 

June 1  
  Session V. Novel technologies in molecular medicine
Chair: Radan Spaventi, Croatia
09:00-09:30 Ursula Klingmueller, Germany
Systems Biology and Cancer
09:30-10:00 Vishva Dixit, USA
Regulation of Inflammation by ubiquitin modification of signaling components
10:00-10:30

Coffee break

10:30-11:00

Philippe Bastiaens, Germany
Modulation of palmitoylated Ras signaling via the dynamic acylation cycle

11:00-11:20 Bojan Zagrovic, Croatia
Computer simulations in the modern molecular biology research
11:20-11:40

Emily Chenette, USA
Signaling Gateway: The Molecule Pages Database

12:00-13:00

Lunch

13:30 Boat trip to neighboring archipelago
Guided tour and free evening in Dubrovnik
23:00 Bus transport from Dubrovnik to Cavtat

 

June 2  
  Session VI. Molecular biology and medicine I
Chair: Ellen Van Obberghen-Schilling, France
09:00-09:30

Maria Masucci, Sweden
Burkitt´s lymphoma: revisiting the pathogenesis of a virus-associated malignancy

09:30-10:00

Kohei Miyazono, Japan
TGF-beta signaling and cancer

10:00-10:20 Koraljka Husnjak, Germany
Proteasome subunit Rpn13 is a novel ubiquitin receptor
10:20-10:50 Coffee break
10:50-11:20

Chris Marshall, UK
Rho GTPases, actomyosin contractility and cell migration

11:20-11:50 Alfred Wittinghofer, Germany
Signaling via Ras-like G proteins
11:50-12:10 Laszlo Nagy, Hungary
The Nuclear Receptors, PPARγ, VDR and RAR Link Lipid Metabolism And Immune Function In Developing Human Dendritic Cells
12:30-14:00

Lunch and afternoon break

14:00-14:30 Meet the Editor II.
   
 

Session VII. Molecular biology and medicine II
Chair: Kohei Miyazono, Japan

15:00-15:30

Clare Isacke, UK
Tumour : stroma interactions in breast cancer

15:30-16:00

Edward Skolnik, USA
Reversible Histidine Phosphorylation of the Potassium Channel KCa3.1 by Nucleoside Diphosphate Kinase B and Protein Histidine Phosphatase-1 Regulates KCa3.1 Activity and the Subsequent Activation of CD4 T Lymphocytes

16:00-16:30

Reinhard Faessler, Germany
Genetic analysis of integrin signalling in mice

16:30-17:00 Coffee break
17:00-17:30 Ellen Van Obberghen-Schilling, France
Cellular fibronectin variants and mechanisms of matrix assembly
17:30-18:00 Richard Marais, UK
18:00-18:20 Krishnaraj Rajalingam, Germany
18:30-20:30 Poster session III.

 

June 3  
  Session VIII. New trends 2008 - Selected Talks
Chairs:
Edward Skolnik, USA and two participants (selection during conference)
09:00-09:20 Yvonne Groemping, Switzerland
The structure of the Eps15-Stonin2 complex provides a molecular explanation for EH domain ligand specificity in endocytosis
09:20-09:40 Marta Moral, Spain
Generation of a mouse model of human head and neck squamous cell carcinoma through somatic activation of akt kinase and tp53 deficiency
09:40-10:00 Tilman Brummer, Germany
The docking protein and proto-oncogene product Gab2 is regulated via a novel negative feedback mechanism mediated by 14-3-3 binding
10:00-10:20 Federica Toffalini, Belgium
The fusion proteins TEL-PDGFRβ and FIP1L1-PDGFRα escape ubiquitination and degradation
10:20-10:50 Coffee break
10:50-11:10 Mirko Schmidt, Germany
Epidermal growth factor-like 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal
11:10-11:30 Pascale Zimmermann, Belgium
Integration of peptide and lipid signaling by PDZ domain scaffold proteins: the syntenin study cases
11:30-11:50 Marc Brehme, Austria
Quantitative Characterization of the Bcr-Abl Core Complex amidst its Physical Protein-Protein Interaction Network
11:50-12:10 Federica Catalanotti, Austria
MEK1 sets the threshold of ERK activation during growth factor-induced migration
12:30-14:00 Lunch and afternoon break
   
  Session IX. Communication and society session organized by EMBO
Chair: Ivan Dikic, Germany
14:00-14:30 Ania Lichtarowicz, Correspondent, BBC World Service, London, UK
Hitting you in the heart or the pocket: what makes news
14:30-15:00 Renee Schröder, Professor, RNA biology, Max F. Perutz Laboratories, Vienna, Austria
The media and me: personal experiences
15:00-15:30 Andrew Moore, Manager, EMBO Science & Society Programme, Heidelberg, Germany
Embroidery or embryology, the choice is yours: taking initiatives in media communication
15:30-16:30 Beach Practical Course: “How to give an interview for media?”
Andrew Moore – up to 15 student (preregistration required)
   
20:00

Farewell Dinner
Poster Award Ceremony
Young Investigator Award
Selected Talk Prize
Fun, DJ and Dancing

 

June 4 Departure